Medtronic plc
MDT
$87.14
-$0.24-0.28%
NYSE
| 01/23/2026 | 10/24/2025 | 07/25/2025 | 04/25/2025 | 01/24/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.81% | 32.12% | -1.52% | -18.39% | 1.89% |
| Total Depreciation and Amortization | 2.86% | -0.57% | 2.03% | 0.73% | 1.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.31% | -44.31% | 47.75% | 152.27% | 78.38% |
| Change in Net Operating Assets | 149.37% | -23.98% | -354.89% | -2.60% | 143.54% |
| Cash from Operations | 196.65% | -14.98% | -56.96% | -1.71% | 168.48% |
| Capital Expenditure | 5.13% | 7.14% | -9.80% | 3.57% | -17.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,557.14% | 93.49% | -593.55% | 88.48% | -555.93% |
| Cash from Investing | -69.29% | 32.96% | -46.73% | 41.87% | -144.35% |
| Total Debt Issued | -149.16% | 285.21% | -- | -- | -- |
| Total Debt Repaid | 100.00% | -52.15% | -- | 100.00% | -280.07% |
| Issuance of Common Stock | 2.50% | 68.42% | -12.04% | -35.71% | 17.48% |
| Repurchase of Common Stock | 71.77% | -202.44% | 55.11% | -51.38% | 37.15% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.11% | 0.00% | -1.45% | 0.00% | 0.00% |
| Other Financing Activities | -20.00% | -107.14% | 125.00% | -275.00% | 426.53% |
| Cash from Financing | -428.35% | 71.40% | -2.83% | 23.39% | -228.28% |
| Foreign Exchange rate Adjustments | 161.54% | -158.21% | -76.33% | 317.69% | -3,350.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,600.00% | 100.95% | -196.63% | 735.06% | -285.54% |